 | • レポートコード：B-GIR09D3757 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アジソン病治療の世界市場について調べ、まとめました。種類別セグメントは、経口コルチコステロイド、コルチコステロイド注射等、用途別セグメントは、病院、診療所、その他等に区分しました。アジソン病治療の世界市場概観、企業動向、企業別アジソン病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アジソン病治療の市場概観 ・アジソン病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アジソン病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・アジソン病治療の世界市場規模 ・アジソン病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・アジソン病治療のアメリカ市場規模推移 ・アジソン病治療のカナダ市場規模推移 ・アジソン病治療のメキシコ市場規模推移 ・アジソン病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アジソン病治療のドイツ市場規模推移 ・アジソン病治療のイギリス市場規模推移 ・アジソン病治療のロシア市場規模推移 ・アジソン病治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アジソン病治療の日本市場規模推移 ・アジソン病治療の中国市場規模推移 ・アジソン病治療の韓国市場規模推移 ・アジソン病治療のインド市場規模推移 ・アジソン病治療の東南アジア市場規模推移 ・アジソン病治療の南米市場分析（ブラジル、アルゼンチン等） ・アジソン病治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アジソン病治療の種類別分析/販売量、売上、市場シェア（経口コルチコステロイド、コルチコステロイド注射） ・アジソン病治療の用途別分析/市場規模（病院、診療所、その他） ・アジソン病治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アジソン病治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Addison’s disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.
Scope of the Report:
The global Addison’s Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addison’s Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Addison’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addison’s Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
GlaxoSmithKline
Shire
Abbott Laboratories
Merck
Boehringer Ingelheim
Amgen
Lupin Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral Corticosteroid
Corticosteroid Injections
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
Table of Contents
1 Addison’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Addison’s Disease Treatment
1.2 Classification of Addison’s Disease Treatment by Types
1.2.1 Global Addison’s Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Addison’s Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Oral Corticosteroid
1.2.4 Corticosteroid Injections
1.3 Global Addison’s Disease Treatment Market by Application
1.3.1 Global Addison’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Addison’s Disease Treatment Market by Regions
1.4.1 Global Addison’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Addison’s Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Addison’s Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Addison’s Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Addison’s Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Addison’s Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Addison’s Disease Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Addison’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Addison’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shire
2.3.1 Business Overview
2.3.2 Addison’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shire Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Addison’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Addison’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Addison’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Addison’s Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Lupin Pharmaceuticals
2.8.1 Business Overview
2.8.2 Addison’s Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lupin Pharmaceuticals Addison’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Addison’s Disease Treatment Market Competition, by Players
3.1 Global Addison’s Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Addison’s Disease Treatment Players Market Share
3.2.2 Top 10 Addison’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Addison’s Disease Treatment Market Size by Regions
4.1 Global Addison’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Addison’s Disease Treatment Revenue by Countries
5.1 North America Addison’s Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Addison’s Disease Treatment Revenue by Countries
6.1 Europe Addison’s Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Addison’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Addison’s Disease Treatment Revenue by Countries (2014-2019)
7.2 China Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Addison’s Disease Treatment Revenue by Countries
8.1 South America Addison’s Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Addison’s Disease Treatment by Countries
9.1 Middle East and Africa Addison’s Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Addison’s Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Addison’s Disease Treatment Market Segment by Type
10.1 Global Addison’s Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Addison’s Disease Treatment Market Forecast by Type (2019-2024)
10.3 Oral Corticosteroid Revenue Growth Rate (2014-2024)
10.4 Corticosteroid Injections Revenue Growth Rate (2014-2024)
11 Global Addison’s Disease Treatment Market Segment by Application
11.1 Global Addison’s Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Addison’s Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Addison’s Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Addison’s Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Addison’s Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Addison’s Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Addison’s Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Addison’s Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Addison’s Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Addison’s Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Addison's Disease Treatment Picture
Table Product Specifications of Addison's Disease Treatment
Table Global Addison's Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Addison's Disease Treatment Revenue Market Share by Types in 2018
Figure Oral Corticosteroid Picture
Figure Corticosteroid Injections Picture
Table Global Addison's Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Addison's Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Addison's Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Addison's Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Addison's Disease Treatment Type and Applications
Table Pfizer Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Addison's Disease Treatment Type and Applications
Table GlaxoSmithKline Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Addison's Disease Treatment Type and Applications
Table Shire Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Addison's Disease Treatment Type and Applications
Table Abbott Laboratories Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Addison's Disease Treatment Type and Applications
Table Merck Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Addison's Disease Treatment Type and Applications
Table Boehringer Ingelheim Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Addison's Disease Treatment Type and Applications
Table Amgen Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Lupin Pharmaceuticals Addison's Disease Treatment Type and Applications
Table Lupin Pharmaceuticals Addison's Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Addison's Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Addison's Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Addison's Disease Treatment Revenue Share by Players in 2017
Figure Global Addison's Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Addison's Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Addison's Disease Treatment Revenue Market Share in 2018
Figure Global Addison's Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Addison's Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Addison's Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Addison's Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Addison's Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Addison's Disease Treatment Revenue by Countries (2014-2019)
Table North America Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Addison's Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Addison's Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Addison's Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Addison's Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Addison's Disease Treatment Revenue Market Share by Countries in 2018
Figure China Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Addison's Disease Treatment Revenue by Countries (2014-2019)
Table South America Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Addison's Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Addison's Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Addison's Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Addison's Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Addison's Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Addison's Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Addison's Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Addison's Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Addison's Disease Treatment Revenue Share by Type in 2019
Table Global Addison's Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Addison's Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Oral Corticosteroid Revenue Growth Rate (2014-2019)
Figure Global Corticosteroid Injections Revenue Growth Rate (2014-2019)
Table Global Addison's Disease Treatment Revenue by Application (2014-2019)
Table Global Addison's Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Addison's Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Addison's Disease Treatment Revenue Share by Application in 2019
Table Global Addison's Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Addison's Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Addison's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Addison's Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Addison's Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Addison's Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Addison's Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Addison's Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Addison's Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Addison's Disease Treatment Revenue Market Forecast (2019-2024)
世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…- 世界のバッテン病治療市場予測（～2024年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Scope of the Report: The global Batten Disease Treatment market is valued at xx milli…
- 世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界の腎疾患治療市場予測（～2024年） Scope of the Report: The global Renal Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…